JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online September 15, 2008
J Nucl Med 2008, doi:10.2967/jnumed.108.051250
© 2008 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.108.051250v1
49/10/1606    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Uesaka, D.
Right arrow Articles by Okazawa, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uesaka, D.
Right arrow Articles by Okazawa, H.


Evaluation of Dual–Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer

Daisuke Uesaka 1, Yoshiki Demura 1*, Takeshi Ishizaki 1, Shingo Ameshima 1, Isamu Miyamori 2, Masato Sasaki 3, Yasuhisa Fujibayashi 4, and Hidehiko Okazawa 4

1 Department of Respiratory Medicine, University of Fukui, Fukui, Japan
2 Third Department of Internal Medicine, University of Fukui, Fukui, Japan
3 Department of Thoracic Surgery, University of Fukui, Fukui, Japan
4 Biochemical Imaging Reserch Center, University of Fukui, Fukui, Japan

* To whom correspondence should be addressed. E-mail: DEM2180{at}aol.com.


   Abstract

18F-FDG PET is increasingly used for lung cancer; however, some insufficient results have been reported. The purpose of this study was to evaluate the efficacy of dual–time-point 18F-FDG PET for staging lung cancer and for differentiating metastatic from nonmetastatic lung cancer lesions. Methods: One hundred fifty-five lung cancer patients with known or suspected mediastinal and hilar lymph node involvement or distant metastases underwent whole-body 18F-FDG PET at 2 time points: scan 1 at 60 min (early imaging) and scan 2 at 180 min (delayed imaging) after 18F-FDG injection. 18F-FDG PET findings of nodal and distant metastases were evaluated using conventional imaging, clinical follow-up findings, and the results of autopsy or biopsy. Results: A total of 580 lesions (155 primary lesions, 315 metastatic lesions, and 110 nonmetastatic lesions) were used for analysis. A closer correlation between the primary lesions and metastases was observed for the retention index (RI) standardized uptake value (SUV) than for early and delayed SUV. There was no relationship between the RI SUV results of primary lesions and those of nonmetastatic lesions. The RI SUV of metastatic lesions was approximately 0.5–2 times the RI SUV of primary tumors. We found that the accuracy of 18F-FDG PET was improved when RI SUV was used for detecting lymph node and distant metastases, because of the significant improvement in specificity relative to early and delayed SUV. Conclusion: RI SUV raised the accuracy for diagnosis of metastases and was superior to early and delayed imaging in terms of differentiating malignancy from nonmetastatic uptake.

Key Words: lung cancer, 18F-FDG PET, staging, dual–time-point imaging, delayed PET




This article has been cited by other articles:


Home page
JNMHome page
R. J. Hicks
Time and Again, Children Resemble Their Parents
J. Nucl. Med., October 1, 2008; 49(10): 1577 - 1578.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.